Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonja M McKinlay

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The New England Journal of Medicine|July 10, 2014
Spironolactone for heart failure with preserved ejection fractionMarc A Pfeffer, Bertram Pitt, Sonja M McKinlay
American Journal of Human Biology : the Official Journal of the Human Biology Council|May 20, 2017
The normal menopause transitionSonja M McKinlay, Donald J Brambilla, Jennifer G Posner
Maturitas|May 13, 2009
The normal menopause transitionSonja M McKinlay, Donald J Brambilla, Jennifer G Posner
American Heart Journal|January 6, 2005
Acute ST-segment elevation myocardial infarction and prior stroke: an analysis from the Magnesium in Coronaries (MAGIC) trialHoward A Cooper, Michael J Domanski, Yves Rosenberg, et al.
European Journal of Heart Failure|November 23, 2016
Data and Safety Monitoring Board evaluation and management of a renal adverse event signal in TOPCATMichael R Bristow, Kavita Sharma, Susan F Assmann, et al.
Circulation. Heart Failure|November 20, 2013
Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trialAmil M Shah, Sanjiv J Shah, Inder S Anand, et al.
The American Journal of Cardiology|January 8, 2019
Comparison of Outcomes in Patients With Diabetes Mellitus Treated With Versus Without Insulin + Heart Failure With Preserved Left Ventricular Ejection Fraction (from the TOPCAT Study)Thao Huynh, Brian J Harty, Brian Claggett, et al.
American Journal of Hematology|September 29, 2011
Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: a phase III analgesic trial for hospitalized sickle cell patients with painful episodesCarlton D Dampier, Wally R Smith, Hae-Young Kim, et al.
Clinical Trials (London, England)|March 30, 2013
IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studiesCarlton D Dampier, Wally R Smith, Carrie G Wager, et al.
Circulation. Heart Failure|August 15, 2014
Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) TrialAmil M Shah, Brian Claggett, Nancy K Sweitzer, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The New England Journal of Medicine|July 10, 2014
Spironolactone for heart failure with preserved ejection fractionMarc A Pfeffer, Bertram Pitt, Sonja M McKinlay
American Journal of Human Biology : the Official Journal of the Human Biology Council|May 20, 2017
The normal menopause transitionSonja M McKinlay, Donald J Brambilla, Jennifer G Posner
Maturitas|May 13, 2009
The normal menopause transitionSonja M McKinlay, Donald J Brambilla, Jennifer G Posner
American Heart Journal|January 6, 2005
Acute ST-segment elevation myocardial infarction and prior stroke: an analysis from the Magnesium in Coronaries (MAGIC) trialHoward A Cooper, Michael J Domanski, Yves Rosenberg, et al.
European Journal of Heart Failure|November 23, 2016
Data and Safety Monitoring Board evaluation and management of a renal adverse event signal in TOPCATMichael R Bristow, Kavita Sharma, Susan F Assmann, et al.
Circulation. Heart Failure|November 20, 2013
Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trialAmil M Shah, Sanjiv J Shah, Inder S Anand, et al.
The American Journal of Cardiology|January 8, 2019
Comparison of Outcomes in Patients With Diabetes Mellitus Treated With Versus Without Insulin + Heart Failure With Preserved Left Ventricular Ejection Fraction (from the TOPCAT Study)Thao Huynh, Brian J Harty, Brian Claggett, et al.
American Journal of Hematology|September 29, 2011
Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: a phase III analgesic trial for hospitalized sickle cell patients with painful episodesCarlton D Dampier, Wally R Smith, Hae-Young Kim, et al.
Clinical Trials (London, England)|March 30, 2013
IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studiesCarlton D Dampier, Wally R Smith, Carrie G Wager, et al.
Circulation. Heart Failure|August 15, 2014
Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) TrialAmil M Shah, Brian Claggett, Nancy K Sweitzer, et al.
Pageof 2